Charge of Rs.600 for collecting samples at home or hospital
The rates for these rapid antibody tests are fixed at Rs 450 for ELSIA for antibody test if the patient goes to the laboratory for testing and Rs 550 for the sample collected at the patient’s home or hospital, while Rs 550 for the patient going to the laboratory for CLIA for antibody test Rates of Rs.500 / – and Rs.600 / – for collecting samples at the patient’s home or hospital have been fixed. The rate includes all types of charges, so that no additional charges can be levied in addition to the above mentioned charges and if a laboratory charges extra, its validity will be automatically revoked, it added.
This price includes all types of charges. The laboratory will not be able to take any other charge apart from this. If taken, its validity will be automatically revoked.
Coronaviruses are a group of RNA viruses that cause diseases in mammals and birds. In humans and birds, they cause respiratory tract infections that can range from mild to lethal. Mild illnesses in humans include some cases of the common cold (which is also caused by other viruses, predominantly rhinoviruses), while more lethal varieties can cause SARS, MERS, and COVID-19. In cows and pigs they cause diarrhea, while in mice they cause hepatitis and
encephalomyelitis. There are as yet no vaccines or antiviral drugs to prevent or treat human coronavirus infections.
COVID-19 testing involves analyzing samples to assess the current or past presence of SARS-CoV-2. The two main branches detect either the presence of the virus or of antibodies produced in response to infection Tests for viral presence are used to diagnose individual cases and to allow public health authorities to trace and contain outbreaks. Antibody tests instead show whether someone once had the disease. They are less useful for diagnosing current infections because antibodies may not develop for weeks after infection It is used to assess disease prevalence, which aids the estimation of the infection fatality rate.
CDC 2019-nCoV Laboratory Test
The US CDC’s COVID-19 laboratory test kit
Individual jurisdictions have adopted varied testing protocols, including whom to test, how often to test, analysis protocols, sample collection and the uses of test results.This variation has likely significantly impacted reported statistics, including case and test numbers, case fatality rates and case demographics. Because SARS-CoV-2 transmission occurs days after exposure (and before onset of symptoms) there is an urgent need for frequent surveillance and rapid availability of results.
Test analysis is often performed in automated, high-throughput, medical laboratories by medical laboratory scientists. Alternatively, point-of-care testing can be done in physician’s offices, workplaces, institutional settings or transit hubs.